Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

Patients with early-stage, hormone receptor–positive breast cancer with favorable clinicopathologic features are often not recommended for extended endocrine therapy. However, even patients with T1N0 disease remain at significant risk of distant recurrence up to 15 years following 5 years of endocri...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Brock, Zhang, Yi, Stål, Olle, Fornander, Tommy, Brufsky, Adam, Sgroi, Dennis C., Schnabel, Catherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543049/
https://www.ncbi.nlm.nih.gov/pubmed/28795152
http://dx.doi.org/10.1038/s41523-017-0037-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543049/
https://www.ncbi.nlm.nih.gov/pubmed/28795152
http://dx.doi.org/10.1038/s41523-017-0037-3

Ejemplares similares